FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

34956911000001107: Gliclazide 40mg tablets (Almus Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Dec 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
105964701000001112 Gliclazide 40mg tablets (Almus Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
105964801000001115 Gliclazide 40mg tablets (Almus Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Gliclazide 40mg tablets (Almus Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Almus Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Almus Pharmaceuticals Ltd) Is a Gliclazide 40mg tablets true Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Almus Pharmaceuticals Ltd) Has active ingredient Gliclazide true Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Almus Pharmaceuticals Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Almus Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Almus Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Almus Pharmaceuticals Ltd) Has specific active ingredient Gliclazide true Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Almus Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Almus Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Gliclazide 40mg tablets (Almus Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Gliclazide 40mg tablets (Almus Pharmaceuticals Ltd) 28 tablet Has AMP True Gliclazide 40mg tablets (Almus Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start